BROKERS CHOICE: QUESSCORP, KIRLOSKERENG, MASTEK, DELHIVERY, AFCONS, GRASIM, INDIGO, TCS, INFOSYS, WIPRO, VEDANTA, SUNPHARMA

AHMEDABAD, 17 DECEMBER: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Antique on Quess Corp: Maintain Buy on Company, target price at Rs 1000/Sh (Positive)

MOSL on Kirloskar Eng: Maintain Buy on Company, target price at Rs 1540/Sh (Positive)

HDFC on Mastek: Maintain Add on Company, target price at Rs 4000/Sh (Positive)

Equirus on Delhivery: Initiate Buy on Company, target price at Rs 459/Sh (Positive)

Investec on Afcons: Initiate Buy on Company, target price at Rs 630/Sh (Positive)

JM Fin on Piramal Pharma: Initiate Buy on Company, target price at Rs 340/Sh (Positive)

Investec on Grasim: Birla Opus is steadily gaining traction amongst customers (positive feedback on product quality/ customer inquiries due to marketing initiatives) (Positive)

Jefferies on IndiGo: Maintains a buy call. Says, its pace of new aircraft deliveries has picked up in past few months. (Positive)

Centrum on Pharma: GOI has allotted Rs10bn for Bulk drug parks to manufacture KSM, Drug Intermediates (DI) and API. Top picks Sun Pharma, JB Chemicals, Medanta, Dr Lal Pathlabs (Positive)

CLSA on IT stocks: TCS, Infosys and Wipro in their quarterly preview showed confidence in improving client sentiments (Positive)

MS on Wipro: Maintain Underweight on Company, target price at Rs 250/Sh (Neutral)

Citi on Vedanta: Maintain Buy on Company, target price at Rs 485/Sh (Neutral)

Investec on Paints: Demand in Q3 FY25 continues to be subdued but expressed hope for a recovery in Q4, Asian Paints and Berger Paints are our fast Sell ideas (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)